Scarica l'app Stockscreener
2.45
4.70%
0.11
Dopo l'orario di chiusura:
2.45
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
ProShare Advisors LLC Acquires 16,801 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
BNP Paribas Financial Markets Purchases New Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio’s (NUVB) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World
Nuvation Bio (NUVB) Price Target Maintained at $6 by JMP Securit - GuruFocus
JMP maintains $6 target on Nuvation Bio stock ahead of PDUFA - Investing.com Nigeria
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Deutsche Bank AG Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Citizens JMP highlights key ASCO presentations - Investing.com
Citizens JMP highlights key ASCO presentations By Investing.com - Investing.com UK
D. E. Shaw & Co. Inc. Sells 63,827 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Millennium Management LLC - Defense World
Nuvation Bio stockholders approve board members and executive pay By Investing.com - Investing.com India
Nuvation Bio Inc. Ratifies the Appointment of KPMG LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 - marketscreener.com
Nuvation Bio Holds Successful Annual Meeting 2025 - TipRanks
Nuvation Bio stockholders approve board members and executive pay - Investing.com
Nuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlook - Investing.com Australia
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting - New Castle News
Northern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $7.83 - Defense World
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - simplywall.st
Wedbush Reiterates Outperform Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUV - GuruFocus
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUVB Stock News - GuruFocus
Dimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025 - BioSpace
Breakthrough Comparison: How Nuvation's Cancer Drug Stacks Up Against Entrectinib in Crucial Lung Cancer Study - Stock Titan
Nuvation Bio Inc. (NYSE:NUVB) Q1 2025 Earnings Call Transcript - Insider Monkey
Nuvation Bio Inc. (NYSE:NUVB) Shares Bought by Price T Rowe Associates Inc. MD - Defense World
Nuvation Bio to Participate in Upcoming May 2025 Investor Conferences - BioSpace
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength - TipRanks
Nuvation Bio to Participate in Upcoming Investor Conferences - Yahoo
Wedbush Issues Positive Outlook for Nuvation Bio Earnings - Defense World
FY2029 Earnings Forecast for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves - Investing.com Canada
Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Insider Monkey
Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon - TipRanks
MetLife Investment Management LLC Buys 12,596 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Earnings call transcript: Nuvation Bio Q1 2025 sees strategic focus amid EPS miss - Investing.com
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Reports Q1 2025 Results and Business Updates - TipRanks
Nuvation Bio (NUVB) Eyes U.S. Approval for Key Lung Cancer Treat - GuruFocus
Nuvation Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Stock Performance Spotlight: Nuvation Bio Inc (NUVB) Ends the Day at 2.09, Down by -12.18 - DWinneX
Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) - Seeking Alpha
Wells Fargo & Company MN Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Shares Down 8.2% After Insider Selling - Defense World
Nuvation Bio Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Sells 322,798 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NUVB) Stock: A Year of Stock Market Dynamics - investchronicle.com
0.87%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):